# Braemar Hotels & Resorts Inc.: financial statements, quarterly

BHR · NYSE · CIK 1574085 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhr.md) · [Financials](/companies/bhr/financials.md) · [Filings](/companies/bhr/filings.md) · [Insiders](/companies/bhr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bhr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [160](/filings/0001574085-24-000228.md) | [178 d](/filings/0001574085-26-000038.md) | [219](/filings/0001574085-25-000051.md) | [188](/filings/0001574085-25-000092.md) | [148](/filings/0001574085-25-000130.md) | [173 d](/filings/0001574085-26-000038.md) | [216](/filings/0001574085-26-000079.md) | [179](/filings/0001574085-26-000130.md) | [144](/filings/0001574085-25-000130.md) | [166 d](/filings/0001574085-26-000038.md) | [209](/filings/0001574085-26-000079.md) | [171](/filings/0001574085-26-000130.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [0.7](/filings/0001574085-24-000228.md) | [5.8 d](/filings/0001574085-26-000038.md) | [42.5](/filings/0001574085-25-000051.md) | [12.2](/filings/0001574085-25-000092.md) | [70.3](/filings/0001574085-25-000130.md) | [3.8 d](/filings/0001574085-26-000038.md) | [36.7](/filings/0001574085-26-000079.md) | [17.9](/filings/0001574085-26-000130.md) | [29.8](/filings/0001574085-25-000130.md) | [(12.1) d](/filings/0001574085-26-000038.md) | [39.6](/filings/0001574085-26-000079.md) | [30.6](/filings/0001574085-26-000130.md) |
| Income tax | $m | [(1.2)](/filings/0001574085-24-000228.md) | [1.6 d](/filings/0001574085-26-000038.md) | [1.5](/filings/0001574085-25-000051.md) | [(0.1)](/filings/0001574085-25-000092.md) | [(0.9)](/filings/0001574085-25-000130.md) | [0.4 d](/filings/0001574085-26-000038.md) | [1.5](/filings/0001574085-26-000079.md) | [(0.3)](/filings/0001574085-26-000130.md) | [(0.6)](/filings/0001574085-25-000130.md) | [1.5 d](/filings/0001574085-26-000038.md) | [1.4](/filings/0001574085-26-000079.md) | [2.5](/filings/0001574085-26-000130.md) |
| Net income | $m | [(22.0)](/filings/0001574085-24-000228.md) | [(19.2) d](/filings/0001574085-26-000038.md) | [15.9](/filings/0001574085-25-000051.md) | [(11.6)](/filings/0001574085-25-000092.md) | [12.6](/filings/0001574085-25-000130.md) | [(18.7) d](/filings/0001574085-26-000038.md) | [11.0](/filings/0001574085-26-000079.md) | [(5.5)](/filings/0001574085-26-000130.md) | [5.7](/filings/0001574085-25-000130.md) | [(33.6) d](/filings/0001574085-26-000038.md) | [17.7](/filings/0001574085-26-000079.md) | [7.0](/filings/0001574085-26-000130.md) |
| Diluted EPS | $ per share | [(0.50)](/filings/0001574085-24-000228.md) | not reported | [0.05](/filings/0001574085-25-000051.md) | [(0.33)](/filings/0001574085-25-000092.md) | [(0.02)](/filings/0001574085-25-000130.md) | not reported | [(0.04)](/filings/0001574085-26-000079.md) | [(0.24)](/filings/0001574085-26-000130.md) | [(0.12)](/filings/0001574085-25-000130.md) | not reported | [0.07](/filings/0001574085-26-000079.md) | [(0.01)](/filings/0001574085-26-000130.md) |
| Basic EPS | $ per share | [(0.50)](/filings/0001574085-24-000228.md) | not reported | [0.05](/filings/0001574085-25-000051.md) | [(0.33)](/filings/0001574085-25-000092.md) | [(0.02)](/filings/0001574085-25-000130.md) | not reported | [(0.04)](/filings/0001574085-26-000079.md) | [(0.24)](/filings/0001574085-26-000130.md) | [(0.12)](/filings/0001574085-25-000130.md) | not reported | [0.07](/filings/0001574085-26-000079.md) | [(0.01)](/filings/0001574085-26-000130.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [149](/filings/0001574085-24-000228.md) | [85.6](/filings/0001574085-26-000038.md) | [137](/filings/0001574085-25-000051.md) | [115](/filings/0001574085-25-000092.md) | [169](/filings/0001574085-25-000130.md) | [135](/filings/0001574085-26-000130.md) | [81.7](/filings/0001574085-26-000079.md) | [80.2](/filings/0001574085-26-000130.md) | [116](/filings/0001574085-25-000130.md) | [124](/filings/0001574085-26-000130.md) | [93.4](/filings/0001574085-26-000079.md) | [93.9](/filings/0001574085-26-000130.md) |
| Total assets | $m | [2,268](/filings/0001574085-23-000103.md) | [2,227](/filings/0001574085-25-000024.md) | [2,281](/filings/0001574085-24-000099.md) | [2,212](/filings/0001574085-24-000201.md) | [2,178](/filings/0001574085-24-000228.md) | [2,136](/filings/0001574085-26-000038.md) | [2,098](/filings/0001574085-25-000051.md) | [2,064](/filings/0001574085-25-000092.md) | [2,009](/filings/0001574085-25-000130.md) | [1,862](/filings/0001574085-26-000130.md) | [1,849](/filings/0001574085-26-000079.md) | [1,659](/filings/0001574085-26-000130.md) |
| Total liabilities | $m | [1,416](/filings/0001574085-23-000103.md) | [1,408](/filings/0001574085-25-000024.md) | [1,466](/filings/0001574085-24-000099.md) | [1,427](/filings/0001574085-24-000201.md) | [1,412](/filings/0001574085-24-000228.md) | [1,414](/filings/0001574085-26-000038.md) | [1,402](/filings/0001574085-25-000051.md) | [1,403](/filings/0001574085-25-000092.md) | [1,373](/filings/0001574085-25-000130.md) | [1,337](/filings/0001574085-26-000130.md) | [1,347](/filings/0001574085-26-000079.md) | [1,180](/filings/0001574085-26-000130.md) |
| Long-term debt | $m | [1,179](/filings/0001574085-23-000103.md) | [1,162](/filings/0001574085-25-000024.md) | [1,223](/filings/0001574085-24-000099.md) | [1,128](/filings/0001574085-24-000201.md) | [1,208](/filings/0001574085-24-000228.md) | [1,210](/filings/0001574085-26-000038.md) | [1,203](/filings/0001574085-25-000051.md) | [1,211](/filings/0001574085-25-000092.md) | [1,165](/filings/0001574085-25-000130.md) | [1,103](/filings/0001574085-26-000130.md) | [1,106](/filings/0001574085-26-000079.md) | [746](/filings/0001574085-26-000130.md) |
| Shareholders' equity | $m | [341](/filings/0001574085-23-000103.md) | [307](/filings/0001574085-25-000024.md) | [307](/filings/0001574085-24-000099.md) | [282](/filings/0001574085-24-000201.md) | [277](/filings/0001574085-24-000228.md) | [241](/filings/0001574085-26-000038.md) | [239](/filings/0001574085-25-000051.md) | [225](/filings/0001574085-25-000092.md) | [212](/filings/0001574085-25-000130.md) | [139](/filings/0001574085-26-000130.md) | [147](/filings/0001574085-26-000079.md) | [147](/filings/0001574085-26-000130.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.0 d](/filings/0001574085-24-000228.md) | [11.7 d](/filings/0001574085-26-000038.md) | [36.0](/filings/0001574085-25-000051.md) | [24.1 d](/filings/0001574085-25-000092.md) | [0.0 d](/filings/0001574085-25-000130.md) | [6.7 d](/filings/0001574085-26-000038.md) | [15.1](/filings/0001574085-26-000079.md) | [23.0 d](/filings/0001574085-26-000130.md) | [(5.8) d](/filings/0001574085-25-000130.md) | [8.3 d](/filings/0001574085-26-000038.md) | [21.9](/filings/0001574085-26-000079.md) | [20.9 d](/filings/0001574085-26-000130.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001574085-23-000103.md) | [0.0 d](/filings/0001574085-24-000033.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [13.3 d](/filings/0001574085-24-000228.md) | [13.1 d](/filings/0001574085-26-000038.md) | [13.1](/filings/0001574085-25-000051.md) | [13.1 d](/filings/0001574085-25-000092.md) | [12.8 d](/filings/0001574085-25-000130.md) | [12.5 d](/filings/0001574085-26-000038.md) | [12.2](/filings/0001574085-26-000079.md) | [12.0 d](/filings/0001574085-26-000130.md) | [11.7 d](/filings/0001574085-25-000130.md) | [11.4 d](/filings/0001574085-26-000038.md) | [11.1](/filings/0001574085-26-000079.md) | [7.3 d](/filings/0001574085-26-000130.md) |
| Share repurchases | $m | [0.0 d](/filings/0001574085-24-000228.md) | [(0.0) d](/filings/0001574085-26-000038.md) | [0.0](/filings/0001574085-24-000099.md) | [0.4 d](/filings/0001574085-25-000092.md) | [0.0 d](/filings/0001574085-25-000130.md) | [0.0 d](/filings/0001574085-26-000038.md) | not reported | not reported | [0.7 d](/filings/0001574085-25-000130.md) | [0.0 d](/filings/0001574085-26-000038.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [71.0](/filings/0001574085-23-000103.md) | [72.5](/filings/0001574085-24-000099.md) | [65.8](/filings/0001574085-24-000201.md) | [65.8](/filings/0001574085-24-000228.md) | [269](/filings/0001574085-25-000051.md) | [66.5](/filings/0001574085-25-000092.md) | [66.5](/filings/0001574085-25-000130.md) | [66.7](/filings/0001574085-26-000079.md) | [67.3](/filings/0001574085-26-000130.md) | [68.2](/filings/0001574085-25-000130.md) | [100](/filings/0001574085-26-000079.md) | [68.7](/filings/0001574085-26-000130.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 68,679,318 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001574085-26-000130.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.